HSBC Holdings’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,525
Closed -$200K 3280
2025
Q1
$200K Buy
+6,525
New +$217K ﹤0.01% 2619
2024
Q4
Sell
-6,398
Closed -$368K 3259
2024
Q3
$368K Buy
6,398
+155
+2% +$7.62K ﹤0.01% 2205
2024
Q2
$253K Sell
6,243
-76
-1% -$3.01K ﹤0.01% 2407
2024
Q1
$265K Buy
+6,319
New +$246K ﹤0.01% 2520
2023
Q1
Sell
-12,745
Closed -$373K 3103
2022
Q4
$373K Buy
12,745
+5,298
+71% +$170K ﹤0.01% 2421
2022
Q3
$302K Sell
7,447
-2,675
-26% -$122K ﹤0.01% 2417
2022
Q2
$394K Sell
10,122
-262
-3% -$9.96K ﹤0.01% 2476
2022
Q1
$513K Buy
10,384
+4,245
+69% +$219K ﹤0.01% 2404
2021
Q4
$447K Buy
6,139
+1,921
+46% +$158K ﹤0.01% 2526
2021
Q3
$384K Buy
+4,218
New +$359K ﹤0.01% 2413

Other funds holding ASTH

HSBC Holdings's ASTH Position: Q2 2025 in Review

HSBC Holdings sold out of Astrana Health (ASTH) in Q2 2025, closing a stake of 6,525 shares — an estimated $200K sold.

HSBC Holdings first reported a position in ASTH in Q3 2021 and held it in 10 quarters. The position peaked at $513K in Q1 2022. 162 funds tracked by Wall St. Rank hold ASTH as of Q2 2025.

  • HSBC Holdings reported no remaining Astrana Health position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 6,525 Astrana Health shares in Q2 2025, an estimated $200K.
  • HSBC Holdings first reported a position in Astrana Health in Q3 2021 and held it in 10 quarters.
  • HSBC Holdings's Astrana Health position peaked at $513K in Q1 2022.
  • 162 funds tracked by Wall St. Rank held Astrana Health as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.